Temperature Mapping in Pharma: Warehouse and Transport Qualification
Temperature mapping is a documented study used to understand temperature distribution within a pharmaceutical storage or transport space. It identifies locations that experience the highest and lowest temperatures so firms can set appropriate monitoring points and controls. WHO TRS 961 Annex 9 and EU GDP expect mapping before use, under representative conditions, with calibrated equipment, and repeated based on risk assessment or after significant modifications.
Key Takeaways
Key Takeaways
- Temperature mapping should be performed before use and under representative or worst-case conditions relevant to the storage or transport system
- Mapping should use calibrated equipment and a documented protocol that explains placement, operating conditions, and acceptance criteria
- Results identify hot spots, cold spots, and optimal locations for continuous monitoring sensor placement
- Remapping is typically driven by risk assessment, significant facility or equipment changes, or findings that show the existing map is no longer representative
- Temperature mapping answers a simple but critical question: does every location in this storage space remain within the acceptable temperature range, under all conditions? A warehouse may show 20C at the monitoring point near the HVAC return duct, but 28C in the corner near the loading dock. Without mapping, that corner's temperature excursion goes undetected, and product stored there degrades.
- Temperature mapping is a common expectation for temperature-controlled storage areas and transport systems where product quality depends on maintaining specified conditions. It supports qualification and the design of the ongoing monitoring system. For how mapping integrates into the broader distribution validation process, see our cold chain validation guide.
- This guide covers the technical approach to temperature mapping, including study design, sensor placement, data analysis, and regulatory expectations.
- In this guide, you'll learn:
- Regulatory requirements for temperature mapping
- Mapping study design and representative operating conditions
- Sensor placement methodology for warehouses, cold rooms, refrigerators, and vehicles
- Data analysis and documentation
- How mapping results inform monitoring system design
- Remapping triggers and ongoing qualification
- ---
Regulatory Requirements
WHO TRS 961 Annex 9
WHO TRS 961 Annex 9 describes temperature mapping as part of the control strategy for time- and temperature-sensitive pharmaceutical products. At a high level, the guidance expects:
- mapping before a storage or transport system is put into use
- representative operating conditions, including conditions that are most likely to challenge temperature control
- calibrated measuring equipment
- documented protocols and reports
EU GDP (2013/C 343/01)
The EU GDP guidelines state that temperature mapping should be performed on the storage area before use, under representative conditions. They also state that monitoring equipment should be located according to the mapping results and that mapping should be repeated based on risk assessment or whenever significant modifications are made to the facility or temperature-controlling equipment.
FDA cGMP Context
FDA's finished-pharmaceutical cGMP regulations do not prescribe a single temperature-mapping method. However, 21 CFR 211.142 requires written warehousing procedures, and 21 CFR 211.166 requires a written stability program whose results are used to determine appropriate storage conditions and expiration dates. In practice, firms use mapping to support those controls for temperature-sensitive storage systems.
Mapping Study Design
Protocol Development
A defensible mapping protocol should define:
- the area or transport system being studied
- the labeled or otherwise established acceptance range
- the operating conditions to be represented, such as loading, door openings, and HVAC or refrigeration operation
- the location and identification of measuring devices
- the calibration status of the equipment
- the approach to data review, excursion assessment, and approval
Representative Conditions
Primary sources support a risk-based approach rather than a universal fixed duration, fixed interval, or fixed sensor-count rule. For that reason, the study should run long enough and under conditions representative enough to show how the space performs during normal and challenging operations.
For transport, EU GDP specifically points to route risk assessment as the basis for determining where temperature controls are required.
Sensor Placement
General Principles
Temperature mapping should evaluate the full three-dimensional space and focus on locations most likely to experience temperature extremes. Typical risk areas include:
- doors and loading areas
- areas close to supply or return airflow
- exterior walls or roofs exposed to ambient heat or cold
- corners, dead zones, or obstructed-airflow areas
- representative product locations within the usable storage space
Practical Application
For warehouses and cold rooms, firms often place devices at different heights and across the footprint of the room so they can identify stratification and localized hot or cold spots.
For refrigerators, freezers, and transport equipment, the same principle applies: device placement should be sufficient to identify the warmest and coldest locations that matter for routine operation and product placement.
Data Analysis
The analysis should identify:
- the highest and lowest temperatures observed
- where and when those extremes occurred
- whether any location fell outside the defined acceptance range
- which locations are most appropriate for ongoing monitoring
The final report should include the protocol, study dates and conditions, measuring-device locations, calibration status, raw or summarized data, identified hot and cold spots, any excursions, conclusions, and follow-up actions.
Informing Continuous Monitoring System Design
Mapping results should be used to position permanent monitoring devices in the locations that best represent the highest-risk temperatures in the space. If mapping shows meaningful stratification or localized extremes, the monitoring design should reflect that rather than relying on a single convenient point.
Remapping Triggers
Temperature mapping is not a one-time exercise. Primary sources support repeating the study when the existing map may no longer represent the system, including:
- significant modifications to the facility or temperature-controlling equipment
- major changes to layout, airflow, or storage configuration
- route or operating changes that materially affect transport conditions
- investigations showing that existing monitoring locations are no longer representative
- periodic reassessment when required by the site's risk-based qualification program
Regulatory References
| Reference | Title | Relevance |
|---|---|---|
| WHO TRS 961 Annex 9 | Model Guidance for the Storage and Transport of Time- and Temperature-Sensitive Pharmaceutical Products | High-level mapping and control expectations |
| EU GDP (2013/C 343/01) | Guidelines on Good Distribution Practice of Medicinal Products for Human Use | Mapping before use, representative conditions, and risk-based repetition |
| 21 CFR 211.142 | Warehousing Procedures | Written storage procedures |
| 21 CFR 211.166 | Stability Testing | Storage conditions and stability program linkage |